Chemotherapy-Induced Neutropenia Treatment Market Size, Share, Analysis, Industry Report and Forecast 2021-2027

The global chemotherapy-induced neutropenia treatment market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Chemotherapy-induced neutropenia occurs in cancer that directly affects the bone marrow. Chemotherapy-induced neutropenia patients require hospitalization. Additionally, the cost of the treatment increases with the anti-infective treatment. The major factor for the growth of the market is the increasing use of chemotherapy for the treatment of cancer coupled with the rising prevalence of cancer across the globe.

According to the National Cancer Institute (NCI), it was estimated that 1,806,590 new cases of cancer will be diagnosed in the US with a mortality rate of 606,520 people in 2020. Additionally, the most common cancers are breast cancer, lung and bronchus cancer, and leukemia, among others. In men, prostate, lung, and colorectal cancers will account for an estimated 43% of all cancers diagnosed while for women, the three most common cancers include breast, lung, and colorectal which will account for an estimated 50% of all new cancer diagnoses in women in 2020.

To Request a Sample of our Report on Chemotherapy-Induced Neutropenia Treatment Market: https://www.omrglobal.com/request-sample/chemotherapy-induced-neutropenia-treatment-market

Furthermore, there were 18.1 million new cases and 9.5 million cancer-related mortalities globally in 2018 which is anticipated to rise to 29.5 million and the number of cancer-related mortalities to 16.4 million by 2040. Hence, the rising prevalence of cancer is increasing the demand for chemotherapy as the first choice of treatment which in turn is driving the growth of the market. Moreover, some major players in the market include Amgen, Inc., Sanofi S.A., and Novartis International AG, among others.

Market Coverage

• The market number available for – 2020-2027

• Base year- 2020

• Forecast period- 2021-2027

• Segment Covered-

· By Type

· By Distriubution Channel

• Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

• Competitive Landscape- Amgen, Inc., Sanofi S.A., and Novartis International AG, among others.

(Get 15% Discount on Buying this Report)

A full Report of Chemotherapy-Induced Neutropenia Treatment Market is Available @ https://www.omrglobal.com/industry-reports/chemotherapy-induced-neutropenia-treatment-market

Global Chemotherapy-Induced Neutropenia Treatment Market Report by Segment

By Therapy Type

• Antibiotic Therapy

• Colony-Stimulating Factor Therapy

• Granulocyte Transfusion

• Splenectomy Procedure

• Others

By Distribution Channel

• Hospital Pharmacy

• Retail Pharmacy

• Online Pharmacy

Global Chemotherapy-Induced Neutropenia Treatment Market Report by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

· Latin America

· Middle East & Africa

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.